SHINE Medical says it will produce 70% of global demand for medical isotope moly-99

SHINE Medical Technologies proposed production facility in the Netherlands. Rendering courtesy of SHINE Medical Technologies.
SHINE Medical Technologies says it will produce 70% of the global patient need for molybdenum-99, a diagnostic isotope used in nuclear medicine. The Janesville-based company is building a production facility for molybdenum-99 or moly-99 in…

Want to Read More?

Paid BizTimes subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In

Or click here to purchase a paywall bypass link for this article.

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

No posts to display